作为晚期或复发性子宫内膜癌的一线疗法，来伐替尼加pembrolizumab与化疗的比较：ENGOT-En9/LEAP-001Ⅲ期研究的初步结果

{"title":"作为晚期或复发性子宫内膜癌的一线疗法，来伐替尼加pembrolizumab与化疗的比较：ENGOT-En9/LEAP-001Ⅲ期研究的初步结果","authors":"Christian Marth , Richard Moore , Mariusz Bidzinski , Sandro Pignata , Ali Ayhan , M. Jesús Rubio , Mario Beiner , Marcia Hall , Christof Vulsteke , Elena Ioana Braicu , Kenzo Sonoda , Xiaohua Wu , Sophia Frentzas , André Mattar , Jodi McKenzie , Lili Yao , Vivek Khemka , Robert Orlowski , Lucy Gilbert , Vicky Makker","doi":"10.1016/j.ygyno.2024.07.094","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":12853,"journal":{"name":"Gynecologic oncology","volume":null,"pages":null},"PeriodicalIF":4.5000,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Lenvatinib plus pembrolizumab versus chemotherapy as first-line therapy for advanced or recurrent endometrial cancer: Primary results of the phase III ENGOT-En9/LEAP-001 study\",\"authors\":\"Christian Marth , Richard Moore , Mariusz Bidzinski , Sandro Pignata , Ali Ayhan , M. Jesús Rubio , Mario Beiner , Marcia Hall , Christof Vulsteke , Elena Ioana Braicu , Kenzo Sonoda , Xiaohua Wu , Sophia Frentzas , André Mattar , Jodi McKenzie , Lili Yao , Vivek Khemka , Robert Orlowski , Lucy Gilbert , Vicky Makker\",\"doi\":\"10.1016/j.ygyno.2024.07.094\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":12853,\"journal\":{\"name\":\"Gynecologic oncology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.5000,\"publicationDate\":\"2024-10-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Gynecologic oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0090825824004499\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"OBSTETRICS & GYNECOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gynecologic oncology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0090825824004499","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}